Experimental design 1
In order to characterise the MoA of BNF and OHT, two different exposure designs were used 2 (table 1). The compounds BNF (AhR-agonist) and OHT (ER-antagonist) were chosen on basis 3 of their differences in MoA and potential interference with E2-induced Vtg protein expression.
4
Testing for the 50% ER-agonistic inhibitory concentration (IC50) was performed in experiment 5 1 to obtain the parameters necessary to design a mixture of BNF and OHT (given in 6 combination with a fixed concentration of E2 of 6.3E
-10 mol/L). This would make it possible to 7 assess whether the inhibitory effects on E2-induced Vtg protein expression observed after 8 exposure to the mixture of BNF, OHT and E2 could be explained by additivity. Cells from three 9 individual cell isolations were exposed to a dilution series of BNF and OHT in presence of a 10 sub-lethal E2 concentration (E2: 6.3E -10 mol/L) causing 50% induction of Vtg protein 11 production.
12
Experiment 2 was performed after the preliminary identification of IC50 values for BNF and
13
OHT in the 24 well format, using four individual cell isolations and exposing them to individual 
Enzyme linked immunosorbent assay (ELISA)

19
Vitellogenin was measured in the primary hepatocyte media by a capture (semi-quantitative) 20 ELISA, previously described by Tollefsen et al. (2003) . In brief, the frozen microtiter plates 21 containing media sampled after 96h of exposure, were thawed at 4°C, followed by application 
Quantitative Real time PCR (qPCR)
12
The gene expression analysis was performed using quantitative (real-time) polymerase chain 13 reaction (qPCR). Synthesis of cDNA was performed through reverse transcription of total RNA
14
(0.5-1 μg) using Quanta qScript™ cDNA Synthesis Kit (Quanta Biosciences Inc., Gaithersburg, reaction (20 μl/reaction). The primers were designed using the NCBI accession number 22 corresponding to the housekeeping and target genes ( CRC parameters for the single compounds from experiment 2 was used in the prediction models 10 to calculate the predicted combined effect of the applied mixture compositions. Eq. 1
Eq. 2
15
ECxmix: the predicted total concentration of the mixture that produces x% effect ECxi: is the concentration of substance i provoking the effect x when applied alone.
18
Emix: the effect of the mixture
19
Ei: the effect of substance i when applied alone.
20
Additivity was assumed if the predicted effects where within the 95% confidence interval (CI) 1 of the experimental data and/or if the model deviation ratios (MDRs, the ratio between the 2 predicted effect concentration and the experimental effect concentration at a certain effect level) 3 was within a factor of two (0.5 ≤ MDR ≤ 2). was significantly different (p=0.0332) from E2 (Fig. 4) , albeit no significant anti-estrogenic 8 effect was identified for BNF or the interactions among the compounds (Suppl. BNF, OHT, and a mixture of these were observed on the vtg-1 gene expression (Suppl. Fig. 1 ). Suppl. Table 2 ). In absence of E2, the compounds BNF, OHT and a mixture of these 9 (BNF+OHT) did not affect zrp expression at the concentrations tested (Suppl. Fig. 1 ). respectively) (Suppl. Fig. 2 , Suppl. Table 2 ). The two-way ANOVA demonstrated that none of Table   9 2). The cyp1a transcription was unaffected by co-exposure of E2. 
ER signalling 8
The present study showed that exposure to BNF and OHT reduced E2-induced Vtg protein 9 expression in a concentration-responsive manner, findings that are similar to previous studies 10 with primary hepatocytes (Gräns et al., 2010; Navas and Segner, 2000; Smeets et al., 1999) .
11
The present study verified that the anti-estrogenic effect of the compounds was dependent on 12 their ability to modulate the activity of the ER without affecting the viability, as suppression 13 of E2-induced Vtg protein expression previously has been suggested caused by cytotoxicity
14
(Navas and Segner, 2000).
15
The currently available studies display that in vitro Vtg protein expression in fish hepatocytes 16 may accommodate multiple anti-estrogenic mechanisms (e.g. ER-antagonism, receptor cross-17 talk), but none of these studies has fully characterised the anti-estrogenic MoA (Gräns et al., cause an anti-estrogenic effect.
In the present study, E2-induced hepatocytes co-exposed with BNF and OHT displayed similar on the cyp1a transcription in cells exposed to BNF alone or in combination with E2 were 4 observed, thus indicating that neither ahr2β nor cyp1a were affected by the presence of E2 at 5 the concentrations tested (Suppl. Fig. 2 ).
6
The OHT anti-estrogenic effect in fish has previously been ascribed to its inhibitory properties and EROD activity through inhibition of protein kinase C (Long et al., 1998; Lai et al., 2004) .
16
As ahr2β was not clearly effected by the treatments, likely due to the low concentration of BNF transcriptional AhR-activation in the binary mixture.
AhR-ER cross-talk 1
To characterize the binary mixture's anti-estrogenic MoA, the present study assessed some of 2 previously proposed cross-talk mechanisms between AhR and ER (Safe and Wormke, 2003) .
3
Cells exposed to BNF in combination with E2 displayed a tendency for lower cyp1a expression 4 than cells exposed in the absence of E2. Although these differences were not statistically 5 significant, the observed trend suggest a potential weak E2-mediated interference with AhR-6 mediated cyp1a transcription. It has previously been proposed that estrogenic compounds (e.g. 
17
To further characterize the possible cross-talk mechanisms involved in the anti-estrogenic 18 effects, the common transcription co-factor aryl hydrocarbon receptor translocator protein Interestingly, arnt was significantly induced in cells exposed to E2 compared to OHT,
24
BNF+OHT (without co-exposure of E2) and the DMSO control (Suppl. Fig. 3 The present study showed that the differently acting anti-estrogenic compounds BNF, OHT Ohtake, F., Takeyama, K., Matsumoto, T., Kitagawa, H., Yamamoto, Y., Nohara, K., The different letters and * denote treatments which are significantly (p ≤ 0.05) different from 7 each other in both the one-way and two-way ANOVA, respectively. 
20
The statistical analysis for the left graph was performed using a one-way ANOVA with a
21
Tukey's post hoc test while the right graph presents a two-way ANOVA using Bonferroni post post hoc test while the right graph presents a two-way ANOVA using Bonferroni post hoc test.
16
The different letters and * denote treatments which are significantly (p ≤ 0.05) different from 17 each other in both the one-way and two-way ANOVA, respectively. 
